VF
CMPX icon

Virtu Financial’s Compass Therapeutics CMPX Stock Holding History

Virtu Financial’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Sell
16,394
-26,672
-62% -$78.7K ﹤0.01% 1273
2026
Q1 		$228K Buy
+43,066
New +$249K 0.01% 956
2025
Q4 		– Sell
-12,681
Closed -$44K – 1749
2025
Q3 		$44K Buy
+12,681
New +$40.1K ﹤0.01% 1151
2024
Q3 		– Sell
-51,233
Closed -$51K – 1448
2024
Q2 		$51K Buy
+51,233
New +$74.8K ﹤0.01% 900
2024
Q1 		– Sell
-28,054
Closed -$44K – 1500
2023
Q4 		$44K Buy
+28,054
New +$48.5K ﹤0.01% 1193

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Virtu Financial's CMPX Position: Q2 2026 in Review

Virtu Financial reduced its Compass Therapeutics (CMPX) stake by 62% in Q2 2026, selling an estimated $78.7K and leaving 16,394 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #1273.

Virtu Financial first reported a position in CMPX in Q4 2023 and has held it in 5 quarters since. The position peaked at $228K in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Virtu Financial held 16,394 shares of Compass Therapeutics worth $36K as of Q2 2026.
  • Virtu Financial sold 26,672 Compass Therapeutics shares in Q2 2026, an estimated $78.7K.
  • Compass Therapeutics made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1273 holding.
  • Virtu Financial first reported a position in Compass Therapeutics in Q4 2023 and has held it in 5 quarters since.
  • Virtu Financial's Compass Therapeutics position peaked at $228K in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.